Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial.
Onuma Y, Chevalier B, Ono M, Cequier À, Dudek D, Haude M, Carrié D, Sabaté M, Windecker S, Rapoza RR, West NEJ, Reith S, de Sousa Almeida M, Campo G, Íñiguez-Romo A, Serruys PW.
Onuma Y, et al. Among authors: de sousa almeida m.
EuroIntervention. 2020 Dec 4;16(11):e938-e941. doi: 10.4244/EIJ-D-20-00024.
EuroIntervention. 2020.
PMID: 32515738
Free article.
Clinical Trial.
No abstract available.